Vanda Pharmaceuticals (NASDAQ: VNDA) just announced that it has received FDA-approval for its new drug known as BYSANTI. The drug is meant to treat Bipolar I manic episodes as well as Schizophrenia ...
A number of stocks jumped in the afternoon session after the Supreme Court struck down sweeping Trump tariffs, bringing potential relief to companies impacted by international trade disputes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results